tetradecanoylphorbol acetate has been researched along with thalidomide in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Nielsen, H; Valerius, NH | 1 |
| Baker, J; Chao, NJ; Chen, Y; Fernandez, LP; Schlegel, PG | 1 |
| Hashimoto, Y; Iwasaki, S; Nishimura, K | 2 |
| Azuma, A; Hashimoto, Y; Hioki, E; Iwasaki, S; Kobayashi, Y; Miyachi, H | 1 |
| Azuma, A; Hashimoto, Y; Iwasaki, S; Miyachi, H; Shibata, Y | 1 |
| Hashimoto, Y; Iwasaki, S; Sasaki, K; Shibata, Y | 1 |
| Barcellini, W; Dalgleish, AG; La Maestra, L; Lazzarin, A; Marriott, JB; Zaninoni, A | 1 |
| Dearman, RJ; Deighton, J; Ewan, PW; Kimber, I; McHugh, SM; Rowland, TL | 1 |
| Aggarwal, BB; Lamothe, B; Majumdar, S | 1 |
| Chen, RS; Haley, M; Hughes, CC; Muller, GW; Naziruddin, SD; Parton, A; Payvandi, F; Schafer, PH; Stirling, DI; Wu, L | 1 |
12 other study(ies) available for tetradecanoylphorbol acetate and thalidomide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Thalidomide enhances superoxide anion release from human polymorphonuclear and mononuclear leukocytes.
Topics: Chemotaxis; Humans; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen Consumption; Superoxides; Tetradecanoylphorbol Acetate; Thalidomide | 1986 |
Does thalidomide affect IL-2 response and production?
Topics: beta-Galactosidase; Cells, Cultured; Clone Cells; Dose-Response Relationship, Drug; Enhancer Elements, Genetic; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-2; Ionomycin; Kinetics; Leukemia; Lymphocyte Activation; Lymphocytes; Tetradecanoylphorbol Acetate; Thalidomide; Transfection; Tumor Cells, Cultured | 1995 |
(S)-form of alpha-methyl-N(alpha)-phthalimidoglutarimide, but not its (R)-form, enhanced phorbol ester-induced tumor necrosis factor-alpha production by human leukemia cell HL-60: implication of optical resolution of thalidomidal effects.
Topics: Cell Division; Chromatography, High Pressure Liquid; Humans; Leukemia, Experimental; Stereoisomerism; Tetradecanoylphorbol Acetate; Thalidomide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Enhancement of phorbol ester-induced production of tumor necrosis factor alpha by thalidomide.
Topics: Cell Line; Drug Synergism; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Tetradecanoylphorbol Acetate; Thalidomide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production.
Topics: Carcinogens; Dose-Response Relationship, Drug; Ethers, Cyclic; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lyngbya Toxins; Molecular Structure; Okadaic Acid; Structure-Activity Relationship; Terpenes; Tetradecanoylphorbol Acetate; Thalidomide; Thapsigargin; Tumor Necrosis Factor-alpha | 1996 |
Augmentation by phthalimides of phorbol ester-induced expression of tumor necrosis factor alpha message.
Topics: Blotting, Northern; Carcinogens; HL-60 Cells; Humans; Isoindoles; Phthalimides; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Thalidomide; Tumor Necrosis Factor-alpha | 1996 |
Benzylphthalimides and phenethylphthalimides with thalidomide-like activity on the production of tumor necrosis factor alpha.
Topics: HL-60 Cells; Humans; Phthalimides; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Thalidomide; Tumor Necrosis Factor-alpha | 1995 |
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
Topics: Anti-HIV Agents; Base Sequence; Cell Line; DNA Primers; Gene Expression; HIV Infections; HIV-1; Humans; In Vitro Techniques; Macrophages; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thalidomide; Tumor Necrosis Factor-alpha; U937 Cells | 2000 |
Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B.
Topics: Adult; Base Sequence; Dexamethasone; DNA Primers; Humans; In Vitro Techniques; Kinetics; Leukocytes, Mononuclear; NF-kappa B; Phytohemagglutinins; RNA, Messenger; Tetradecanoylphorbol Acetate; Thalidomide; Tumor Necrosis Factor-alpha | 2001 |
Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester.
Topics: Antigens, CD; Cell Line; Ceramides; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Genes, Reporter; HeLa Cells; Humans; Hydrogen Peroxide; I-kappa B Kinase; I-kappa B Proteins; Immunosuppressive Agents; Jurkat Cells; Kidney; Lipopolysaccharides; Myeloid Cells; NF-kappa B; NF-KappaB Inhibitor alpha; NF-kappaB-Inducing Kinase; Okadaic Acid; Protein Serine-Threonine Kinases; Proteins; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tetradecanoylphorbol Acetate; Thalidomide; TNF Receptor-Associated Factor 2; Tumor Necrosis Factor-alpha; U937 Cells | 2002 |
Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.
Topics: Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression Regulation; Humans; Immunologic Factors; Interleukin-2; Ionomycin; Ionophores; Isoenzymes; K562 Cells; Killer Cells, Natural; Lymphocyte Activation; Protein Kinase C; Protein Kinase C-theta; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thalidomide; Transcription Factors | 2005 |